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Abstract.  The venom protein,  s-echistatin, originally 
derived from the saw-scaled viper Echis carinatus, 
was found to be a  potent inhibitor of bone resorption 
by isolated osteoclasts: This Arg24-Gly2S-Asp26-(RGD)- 
containing protein inhibited the excavation of bone 
slices by rat osteoclasts (IC50 =  0.1  nM).  It also in- 
hibited the release of [3H]proline from labeled bone 
particles by chicken osteoclasts (IC50 =  100 nM).  By 
comparison, the tetrapeptide Arg-Gly-Asp-Ser (RGDS) 
inhibited resorption by rat or chicken osteoclasts with 
an IC~o of 0.1  mM while ala24-echistatin was inactive. 
Video microscopy showed that rat osteoclast attach- 
ment to substrate was more sensitive to s-echistatin 
than was the attachment of mononuclear cells or 
chicken osteoclasts. The difference in sensitivity of rat 
and chicken osteoclasts to s-echistatin may be due to 
differences between receptors on rat and chicken os- 
teoclasts for s-echistatin. Antibody localization of 
echistatin on these cells showed much greater echista- 
tin binding to rat osteoclasts than to chicken os- 
teoclasts. Laser scanning confocal microscopy after 
immunohistochemical staining showed that s-echistatin 
binds to osteoclasts, that s-echistatin receptors are 
most abundant at the osteoclast/glass interface, and 
that s-echistatin colocalizes with vinculin. Confocal 
interference reflection microscopy of osteoclasts in- 
cubated with s-echistatin, demonstrated colocalization 
of s-echistatin with the outer edges of clusters of grey 
contacts at the tips of some lamellipodia. Identification 
of the echistatin receptor as an integrin was confirmed 
by colocalization of echistatin fluorescence with stain- 
ing for an a-like subunit.  Attachment of bone parti- 
cles labeled with [3H]proline to chicken osteoclasts 
confirmed that the mechanism of action of echistatin 
was to inhibit osteoclast binding to bone presumably 
by disrupting adhesion structures.  These data demon- 
strate that osteoclasts bind to bone via an RGD- 
sequence as an obligatory step in bone resorption, that 
this RGD-binding integrin is at adhesion structures, 
and that it colocalizes with vinculin and has an o~-like 
subunit. 
O 
TEOCLASTS are multinucleated cells up to 400/zm 
in diameter that resorb  mineralized tissue in ver- 
tebrates. Bone resorption appears to proceed by the 
intricate  coordination  of the  processes  of attachment to 
bone, polarized secretion of acid and proteases, and active 
motility of osteoclasts along the bone substrate (Kanehisa 
and Heersche, 1988; Baron et al.,  1988; Blair et al., 1989; 
Zambonin-Zallone et al.,  1989).  Cells active in resorption 
are tightly apposed to the bone surface and form specialized 
structures at this interface consisting of a highly convoluted 
membrane  called the  "ruffled border"  surrounded by  an 
actin-rich region, called the "clear zone" (Vaes,  1988;  Sato 
and Rodan, 1989).  Vinculin is also localized here as shown 
by laser confocal microscopy (Taylor et al.,  1989) and this 
region probably corresponds to the proposed cellular adhe- 
sive structures termed podosomes (Marchisio et al.,  1984; 
Zambonin-Zallone et al.,  1989). 
The molecular mechanisms by which osteoclasts attach to 
bone are not well understood. By analogy to other cells, 
members  of the  integrin  superfamily of divalent cation- 
dependent adhesion molecules may mediate this interaction. 
Integrins are heterodimeric glycoproteins of a  and/3 sub- 
units that participate in both cell-substrate and cell-cell in- 
teractions  (Hynes,  1987).  The  superfamily is  subdivided 
into several families defined by the highly disulfide-linked/3 
subunit. These are the VLA/fibronectin (/30 receptors, the 
leukocyte Leu-CAM/ CD18  (/32) receptors,  the ~3  recep- 
tors, and the epithelial cell/3, receptor (Kajiji et al., 1983). 
The/33 family, also called cytoadhesins, include the platelet 
GP IIblIIa complex that is essential for platelet aggregation 
and  a  vitronectin receptor  (~v/33). Integrins  immunologi- 
cally related to the C~v/33 vitronectin receptor are also found 
on osteoclastoma-derived osteoclasts, osteoblasts, and os- 
teosarcomas (Oldberg et al., 1988b;  Horton, 1988; Dedhar 
et al.,  1987; Zambonin-Zallone et al.,  1989).  Antibodies 
recognizing this integrin inhibit bone resorption and so it 
may function to anchor resorbing cells to bone (Chambers 
et al., 1986; Davies et al., 1989). Two additional/3 subunits, 
/3x and /3s associated with the vitronectin av  subunit have 
also been described on adenocarcinoma and osteosarcoma 
cells, respectively (Cheresh et al., 1989; Freed et al., 1989). 
The relation of these two "vitronectin receptors" to the inte- 
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ing to note that bone sialoprotein, an RGD-containing bone 
matrix protein, and vitronectin share some sequence homol- 
ogy around  the  RGD  sequence  (Oldberg  et  al.,  1988a). 
Thus,  several  pieces  of  data  suggest  that  a  vitronectin 
receptor-like integrin may mediate osteoclast attachment to 
bone, and hence bone resorption. 
Ligand binding to integrins of the ~1  and ~3 family is 
mediated  via  arginine-glycine-aspartic  acid  (RGD) ~ se- 
quences  within the ligands  (Hynes,  1987).  The  integrins 
recognize small peptides containing the RGD sequence, and 
affinity chromatography using RGD-containing peptides has 
been used to purify integrins from osteosarcomas (Freed et 
al., 1989; Oldberg et al., 1988b; Dedhar et al., 1987). How- 
ever, small RGD-containing peptides bind relatively weakly 
to integrins, and thus micromolar concentrations are needed 
to inhibit ligand binding and subsequent integrin-mediated 
functions (Ruoslahti and Pierschbacher,  1987). 
We and others have recently isolated from viper venom a 
family of RGD-containing proteins that bind to platelet GP 
IIblIIa and inhibit integrin function at nanomolar concentra- 
tions (Gan et al., 1988; Huang et al., 1989; Shebuski et al., 
1989;  Knudsen  et  al.,  1988).  One  of these  proteins  is 
echistatin which was purified from the venom of the saw- 
scaled viper Echis carinatus (Gan et al., 1988). This 49 resi- 
due, 5,400-D protein contains four disulfide bridges and in- 
hibits the fibrinogen-dependent platelet aggregation induced 
by ADP (IC50 =  30 nM). This is an integrin-mediated func- 
tion.  Echistatin was  chemically synthesized and synthetic 
echistatin (s-echistatin)  was indistinguishable from native 
echistatin by reverse-phase HPLC, amino acid composition, 
CD spectra, electrophoretic mobility, or biological activity 
(Garsky et al., 1989). Chemical synthesis with ornithine or 
alanine substituting for arginine or tyrosine substitution for 
glycine verified the importance of the RGD in echistatin. We 
therefore sought to ascertain the role of the RGD sequence 
for cell adhesiveness in osteoclast function by using s-echi- 
statin and other RGD-containing peptides.  The data presented 
here suggest that an RGD-mediated adhesion via an integrin 
is essential for bone resorption.  A preliminary account of 
these experiments was presented at the American Society for 
Cell Biology meetings,  1989. 
Materials and Methods 
Osteoclast Primary Cultures 
Osteoclasts were isolated from the long bones of 1-3-d-old rats as described 
by Chambers et al. (1984). Femora, tibiae, and humera were dissected clean 
of soft tissue, split, and scraped with scalpels into  199 media, pH 7-7.2, 
10%  heat-inactivated FCS,  penicillin G,  streptomycin sulfate,  and  am- 
photericin B (Gibco Laboratories, Grand Island, NY). After gentle pipet- 
ting 60×  with a wide bore pipette, the cell suspension was passed through 
a 110-#m nylon mesh (Spectrum Medical, Los Angeles, CA) and aliquoted 
onto plastic dishes (Costar Data Packaging Corp., Cambridge, MA), No.  1 
coverslips (Coming Glass Works, New York, NY), glass cuvettes (Hellma 
Cells, Inc., Jamaica, NY), or bone slices (Arnett and Dempster, 1987). All 
experiments with rat osteoclast cultures were conducted within the first 24 h 
after isolation. 
Osteoclasts from chickens were isolated by the methods of Zambonin- 
Zallone et al. (1982) and Blair et al. (1986).  Medullary bone was harvested 
from split femora and tibiae of laying hens (Dekalb XL) maintained on a 
calcium-deficient  diet (5070C- 9: Purifia Mills Inc., St. Louis, MO) for 3-6 
wk. The bone suspension was washed in PBS at 4 °C, pressed through a 110- 
/~m nylon mesh, and incubated in 0.2% NaCI for 3 min at 37°C to lyse red 
1. Abbreviation  used in this paper:  RGD,  arginine-glycine-aspartic acid. 
blood cells. Cells were collected by centrifugation at 350 g for 5 min at 4°C, 
and then sedimented through 70% serum for 90 min at 4°C in 50-ml tubes 
(Fisher Scientific Co., Pittsburgh, PA). The bottom 5 ml from the preceding 
step was layered over a discontinuous Nycodenz gradient (Accurate Chemi- 
cal & Scientific Corp., Westbury, NY) (1.073, 1.099, 1.143 g/cm  3) and cen- 
trifuged at 350 g for 20 min at 4°C. Cells from below the first band (mono- 
cytes) to above the pellet were pooled and resuspended into alpha-MEM, 
pH  7-7.2,  10%  serum,  antibiotics  (Gibco  Laboratories),  and  5  #g/ml 
cytosine-l- B- D-arabinofuranoside (Sigma Chemical Co., St. Louis, MO), 
at  4°C.  Viable cells  (excluding erythrocytes) were aliquoted  at  1-2  × 
106/cm  2 into 48-well plates (Costar Data Packaging Corp.), no.  1 cover- 
slips, or cuvettes (Fisher Scientific Co.). Osteoclasts typically comprised 
10-50%  of the total cell population although many were nonviable. 
Resorption Assays 
Resorption of  bone by osteoclasts was measured either by analysis of resorp- 
tion pits excavated by osteoclasts on slices of bovine femur or by the release 
of [3H]proline  from  radiolabeled bone particles  in  the presence of os- 
teoclasts (Sato and Grasser, 1990; Blair et al., 1986).  In most experiments, 
the resorptive ability of rat osteoclasts was measured by the resorption pit 
assay while chicken osteoclasts were used in the proline release assay. 
For the resorption pit assay, bone slices (4.4  x  4.4 ×0.2 mm) were cut 
from the diaphysis of bovine femur with a low-speed diamond saw (Isomet, 
Buehler Ltd., Lake Bluff, IL) and stored in 70%  ethanol, at 4°C (Arnett 
and Dempster, 1987).  Slices were rehydrated into 0.1 rnl complete 199 me- 
dia (rat cells) or complete alpha-MEM media (chicken cells) in a 96-well 
plate (Costar) before use. After 15-18 h incubation at 37°C, 5 % CO2, with 
osteoclasts and  RGD-containing peptides, bone  slices were devitalized, 
fixed, dehydrated, and stained with 1% toluidine blue (Arnett and Demp- 
ster, 1987).  Resorption pits were quantitated by digital image processing of 
slices viewed under reflected light microscopy with crossed polarizers and 
rotatable lambda/4 plate (Sato and Grasser,  1990). 
[3Hlproline (Amersham Corp., Arlington Heights, IL) release from ra- 
diolabeled bone particles was measured as described in Blair et al. (1986). 
Chicken osteoclasts in 48-well plates (Costar, Cambridge, MA) were washed 
3×  in complete alpha-MEM media and then incubated for 1-3 d with 100 
/~g of 20-53 /~m particles of crushed rat bone radiolabeled in vivo with 
[3H]pmline  (Blair et al., 1986).  Standard curves to convert dpm to/Lg bone 
were generated by measuring radioactivity in samples hydrolyzed at 110°C 
in 6 N HCI for 1 d or samples ashed in a Packard 306 oxidizer (Packard 
Inst., Sterling, VA). 
Examination of resorption as a function of time (see Fig. 1) showed maxi- 
mum osteoclastic activity of chicken cells between days 5-6 in culture. 
Therefore, for 1-d resorption experiments, unlabeled bone particles (50 p.g, 
<20 #m fraction) were first added to chicken cells at day 3 followed by 
13H]proline-labeled bone (100 l~g, 20-53 /~m) and test compounds at day 
5. Alternatively, [3H]proline-labeled bone (100 t~g) plus compounds were 
added at day 3. In both cases, radioactivity released to th  e media was mea- 
sured at day 6 with a liquid scintillation counter (LKB Instruments, Inc., 
Gaithersburg, MD). 
Attachment Assays 
Attachment of bone to chicken osteoclasts was determined after addition of 
100  /~g/well  of  [3H]proline-labeled bone  particles  (20-53  ttm)  to  os- 
teoclasts cultured in 48-well plates. Unbound bone was defined as particles 
liberated by 3×  swirling of cultures with media, while the bound pool was 
defined as particles liberated after 6 h incubation in 1 N NaOH. All cells 
were completely disrupted by the latter treatment. Samples were then ashed 
in a  Packard 306 oxidizer (Camberra Inst.) and radioactivity measured 
(LKB Instruments, Inc.).  Data are reported as fraction of bone particles 
bound. 
Synthetic Peptides 
s-Echistatin and ala  24 echistatin were synthesized as previously described 
(Garsky  et  al.,  1989).  Reduced carboxamidomethylated echistatin was 
made by dissolving 2 mg s-echistatin in 0.4 ml of Gn buffer (6 M guanidine 
HC1,  1 mM EDTA, 50 mM Tris, pH 8.2) with 30 mg DTT and incubating 
at 40°C for 90 min under N2.85 mg iodoacetamide was added to the mix- 
ture and incubated for an additional 40 rain under N2.  The reaction mix- 
ture was chromatographed by C-18 reversed phase HPLC (Waters Associ- 
ates, Millipore Corp., Milford, MA), and fractions were dried and analyzed 
on a  protein sequencer (model 470A;  Applied Biosystems, Foster City, 
CA), (Gan et al.,  1988) to confirm carboxamidation of cysteines. 
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Figure  1.  Resorption by chicken osteoclasts with time.  The bone 
resorption activity of chicken cells on bone slices was compared 
with parallel cultures incubated with bone particles labeled with 
[3H]proline. Resorption of bone slices (A) was measured by quan- 
titating resorption lacunae stained with toluidine blue by reflected 
light microscopy with crossed polarizers (Sato and Grasser,  1990). 
Resorption with bone particles (B)was measured by quantitating 
the release of tritium into the media as described by Blair et al. 
(1986). The conditions for these experiments were 1,320 +  294 os- 
teoclasts/cm  2 with an average of 4.5  +  1.3 particles/osteoclast as 
counted on day 4. Maximal resorption by either assay was observed 
between days 3-6 in culture. For this reason, resorption assays with 
RGD-containing peptides were conducted between days 3-6 or 5-6 
in culture. 
the surfaces  of the optics when collecting interference refection images. 
The quarter wave plate on the antiflex objective was rotated to 45 ° with re- 
spect to the laser polarization plane to allow reflections from the specimen 
to pass through the polarizer in front of the photomultiplier. 
Results 
RGD-containing peptides were observed to inhibit bone re- 
sorption as shown in Fig.  2.  Chicken osteoclasts and [3H]pro- 
line-labeled bone particles (20-53/zM)  or rat osteoclasts on 
bone slices were incubated with different concentrations of 
RGDS,  s-echistatin,  or  prostaglandin  E2.  Chicken  and rat 
osteoclasts  were  more  sensitive to  s-echistatin (ICs0  =  0.1 
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Photomicrography 
The effects of RGD-containing peptides on osteoclasts  were recorded with 
a Newvicon camera (Image Technology Corp., New York) through a Nikon 
diaphot with a Sony VO-5800H  video cassette recorder.  Images were pho-  120 
tographed off the monitor screen by spatial filtering with a ronchi ruling in 
front of the 35mm camera (Nikon)  as described in InDue (1986).  ~  1 00 
Osteoclasts  on glass coverslips  were prepared for immunofluorescence  -~ 
by washing in buffer P (60 mM Pipes, 25mMHepespH6.9,  10mMEGTA,  ~  80 
2 mM MgSO4) at 37°C  for 2 min before  fixing in 10% formaldehyde  in  3 
buffer  P  (pH  7.0) for  2  min and then rinsing  in 0.9%  NaC1, 0.01 M  v 
Na2HPO4, pH 7.4 (PBS). Coverslips  were incubated in primary antiserum  ~  60 
followed by FITC-IgG (Cooper Biomedical, Inc., Malvern, PA) for 60 min  ~_ 
at room temperature.  Specimens  were mounted in PBS-glycerol  (1:1) with  ~  40 
1% n-propylgallate  (Sigma Chemical Co.) and observed through a Nikon 
Microphot. mAbs (VIN-11-5) to vinculin were  purchased from ICN Im-  cr  20 
munobiologicals  (Lisle, IL). The 23C6 mAb to the c~v subunit was a gener- 
ous girl from M. Horton (St. Bartholomew's  Hospital, London, England). 
Laser  Confocal  Microscopy 
Osteoclasts were imaged with a laser scanning confocal microscope  (model 
MRC-600; BioRad,  Cambridge, MA) utilizing epifluorescence,  and inter- 
ference refection contrast.  Illumination with the 488-nm line of an argon 
ion laser was used in collecting simultaneous confocal epifluorescence  and 
confocal interference refection contrast images. Alternatively,  illumination 
with both the 514- and 458/466-nm lines of the argon laser was used in col- 
lecting two simultaneous confocal interference refection contrast images, 
followed by simultaneous confocal epifluorescence  and nonconfocal  trans- 
mitted images using the 488-nm line. 
Interference refection images were collected using an antiflex 63 ×/1.2 
NA (Carl Zeiss, Inc., Thornwood,  NY)  objective (Bereiter-Hahn et al., 
1979;  Bailey and Gingell,  1988).  Epifluorescence  images  were collected 
with the same objective or with a 60×/1.4 NA Planapo (Nikon) objective. 
Where necessary, images collected using the 60 x  objective were magnified 
by a factor of 1.05 using digital interpolation to bring them to the same final 
magnification  as those collected with the 63x  lens. 
A polarizer rotated 90  ° with respect to the plane of laser polarization 
was positioned in front of the photomultiplier to eliminate reflectance from 
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Figure 2.  Effect of RGD-containing peptides on bone resorption. 
Bone resorption by chicken osteoclasts (A) and rat osteoclasts (B) 
was measured as a  function of different concentrations of s-echi- 
statin ([2),  RGDS tetrapeptide (o),  or prostaglandin E2  (zx). The 
resorption activity of chicken ceils was measured with bone parti- 
cles labeled with [3H]proline between days 5-6 in culture; and rat 
osteoclast activity was measured on bone slices after 1 d in culture. 
Both were sensitive to RGDS with IC50 =  10-100/zM.  The activ- 
ity of both were more sensitive to s-echistatin with IC50 =  0.1 #M 
for chicken and IC50 =  0.1  nM for rat osteoclasts.  For compari- 
son,  prostaglandin  E2  effects  on  resorption  was  examined  for 
chicken osteoclasts as shown previously for mammalian osteoclasts 
(Chambers  et  al.,  1985).  Maximum  resorption  (100%)  with 
chicken cells corresponded  to  13-31  /~g bone resorbed  (n  =  6, 
mean +  SD).  Maximum resorption (100%) in rats corresponded 
to 21-153 pits/slice in which two to three slices were measured for 
each dose of a  series (n  =  4,  mean  +  SEM). 
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Figure 3. Importance of the RGD sequence and the tertiary struc- 
ture of echistatin  on resorption.  The effect of ala  24 echistatin,  in 
which Arg  24 was substituted  with Ala on resorption  (A) was exam- 
ined.  For the  range  of 34 pM-3.4  #M,  ala  24 echistatin  had no 
significant effect (P >  .07, students t test) on the resorption  activity 
of either chicken (<3) or rat (o) osteoclasts  as compared to con- 
trois.  Reduced  echistatin  (B) also had no significant  effect on re- 
sorption as compared to controls for the range  2.4 pM-14 #M. 
Maximum  resorption  (100%)  corresponded to 99-197  lacunae/ 
slice  in rat (n  =  4) and 9-51  /zg bone resorbed for chicken os- 
teoclasts  (n  =  3-12). 
(IC50 =  10-100 #M chicken,  100 #M rat).  s-echistatin was 
1,000-fold more potent at inhibiting pit formation by rat os- 
teoclasts  than  at  inhibiting  [3H]proline  release  by chicken 
osteoclasts in 1-d resorption assays. By comparison, prosta- 
glandin E2 inhibited  resorption of chicken osteoclasts with 
IC5o =  1 #M  (Chambers  et al.,  1985;  Arnett and Demp- 
ster,  1987). 
To explore the importance of the RGD sequence in s-echi- 
statin in inhibiting bone resorption,  osteoclasts were incu- 
bated with ala  24 echistatin in which alanine was substituted 
for arginine in the RGD sequence of echistatin.  This mole- 
cule had insignificant effects (P > 0.07, students t test) on the 
resorption activity of chicken or rat osteoclasts for the range 
30 pM-3 #M  (Fig.  3 A).  Thus,  Arg in the RGD sequence 
is critical for s-echistatin's inhibition of osteoclast-mediated 
bone resorption. 
Osteoclasts  were  incubated  with  reduced  echistatin  to 
ascertain  the  structural  contribution  of the  four disulfide 
bonds to this activity. All eight cysteines in s-echistatin were 
confirmed to be carboxamidomethylated by Edman degrada- 
tion  sequence  analysis  while  the  rest  of the  sequence  re- 
mained intact.  Reduced echistatin had little effect, suggest- 
ing that the tertiary structure defined by the disulfide bonds 
is important to inhibit resorption  (Fig.  3 B). 
Attachment experiments showed that s-echistatin prevents 
bone from binding to osteoclasts (Fig. 4).  Free and bound 
particles of bone labeled with [3H]proline were assayed as a 
function of incubation time  with  chicken osteoclasts  after 
5-6 d in culture at 37°C. s-echistatin (14 nM) significantly 
inhibited the attachment of bone particles to osteoclasts up 
to  150  min.  Ala  24  echistatin  (14  nM)  had  no  significant 
effect on the kinetics of bone particle attachment to osteo- 
clasts. At this s-echistatin concentration, no significant effects 
on osteoclast morphology or resorption were observed dur- 
ing 4 h of observation. Changes in either resorption activity 
or cell area would artificially affect the measured bound pool 
of  bone in this assay. These data show that the RGD sequence 
is necessary for bone attachment to osteoclasts and suggest 
that the inhibition of resorption by s-echistatin is a result of 
blocking osteoclast attachment to bone. 
Osteoclasts incubated on glass with RGD-containing pep- 
tides  were observed to retract  lamellipodia  preceding  de- 
tachment as viewed by video microscopy (Fig.  5).  Rat or 
chicken osteoclasts were incubated with different concentra- 
tions  of RGDS,  s-echistatin,  and  ala24-echistatin.  All  of 
these peptides  induced  morphological changes but rat os- 
teoclasts examined on glass within 1 d of isolation retracted 
lamellipodia at l@-fold lower concentrations of s-echistatin 
(4.3 nM) than RGDS. At this concentration of echistatin the 
lamellipodia of mononuclear cells in the vicinity were not 
affected.  The lamellipodia of rat osteoclasts did not retract 
in  10  #M  RGDS,  43  pM  echistatin,  or  4.1  nM  ala  24- 
echistatin  for up to 2  h  of incubation.  At these concentra- 
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Figure  4.  Effect of echistatin on bone attachment to osteoclasts. 
Bone particles (20-53/zm) labeled with 3H proline were incubated 
with chicken osteoclasts  (3,000/cm 2) as a function of time to ex- 
amine the effect of the following on attachment: media alone (o), 
media with  14 nM echistatin  (n), or with  14 nM ala  24 echistatin 
(<3). The fraction bound to osteoclasts  is plotted  with time (mean 
±  SD, n =  4). s-echistatin  at 14 nM inhibited  attachment to bone 
for 150 rain. 
The Journal of Cell  Biology,  Volume  111,  1990  1716 Figure 5.  Morphology of osteoclasts treated with RGD peptides.  Rat osteoclasts were treated with RGDS (0.1 mM), echistatin (4.3 nM), 
or ala  24 echistatin (4.1  nM),  and followed with time (0', 30', 60'). 0.1 mM RGDS (A-C) and 4.3 nM echistatin (D-F) induced retraction 
of osteoclast lamellipodia but  not 4.1  nM  ala  24 echistatin.  A  concentration  of 34  nM  ala24-echistatin  was  necessary  to  induce  similar 
effects. Rat osteoclasts retracted lamellipodia at concentrations that had little effect on mononuclear cells.  Chicken osteoclasts at  1 d  of 
culture retracted lamellipodia at 6/~M echistatin and were unresponsive up to  10 #M ala  24 echistatin.  Bar,  10/~m. 
Sato et al. Echistatin Inhibits Bone Resorption in Culture  1717 Figure 7. Echistatin colocalizes with vinculin at the substrate.  Rat osteoclasts were incubated with 0.7 nM echistatin  and stained with antisera 
followed by mAb to vinculin. Echistatin fluorescence  of the cell  (A) was most intense  at the substrate  focal plane but some staining  of 
the dorsal membrane was observed. Vinculin staining (B) was also most intense at the substrate.  As indicated by the arrowheads,  echistatin 
colocalized with  vinculin-containing structures.  Note that only rat osteoclasts  stained  for echistatin and vinculin (A) as compared to 
mononuclear cells  which are identified  by vinculin staining  (*, B).  Bar,  10 #m. 
the  lamellipodia  increased  relative  to  controls.  At  34  nM 
Ala  24 echistatin,  lamellipodia retraction did occur. Chicken 
osteoclasts were observed 1 d after isolation retracted lamel- 
lipodia and eventually detached in response to similar con- 
centrations  of RGDS peptide  (0.1  mM) but required  103 x 
higher concentrations of echistatin (6/~M)  compared to rat 
osteoclasts  (Fig.  5). 
Immunofluorescence  with  antisera  to  echistatin  showed 
that more s-echistatin binds to rat osteoclasts than to nearby 
mononuclear cells or to chicken osteoclasts (Fig. 6). Parallel 
exposures of rat and chicken osteoclasts cultured for 1 d and 
incubated  with  s-echistatin  (7  nM)  showed that  rat  osteo- 
clasts  with  four nuclei  were  6.4-fold brighter  than  similar 
chicken osteoclasts by the equation (fluorescence =  1/expo- 
sure time -1/background). At higher concentrations of up to 
10 #M s-echistatin,  the immunofluorescence of chicken os- 
teoclasts approached that of rat osteoclasts at 7  nM.  These 
pharmacological  and  immunohistochemical  data  suggest 
that rat osteoclasts have higher affinity for echistatin than do 
mononuclear cells or chicken osteoclasts, but that the total 
number of s-echistatin  binding  sites  may be similar. 
Vinculin immunofluorescence colocalizes with the stain- 
ing for s-echistatin at the osteoclast/glass interface.  Rat os- 
teoclasts incubated with 0.7 nM echistatin plus antisera and 
mAb to vinculin showed similar, but not identical,  distribu- 
tions of the antigens when focused at the substrate  (Fig.  7, 
A and B). s-echistatin immunofluorescence was observed all 
over rat osteoclasts but was most intense at the cell/glass in- 
terface. The vinculin staining however was localized to spots 
and a few circles at the substrate,  reminiscent of podosome 
structures  shown  previously  for  chicken  and  rabbit  os- 
teoclasts (Marchisio et al.,  1984; Turksen et al.,  1988).  As 
depicted  with  arrowheads,  regions  of echistatin  were  ob- 
served to colocalize with vinculin staining (Fig. 7, A and B). 
By  contrast,  rat  osteoclasts  incubated  with  1  nM  ala  24- 
echistatin for 10 min at 37°C showed no detectable staining 
with echistatin antisera. Fluorescence with excess echistatin 
(1/~M) added with or after antisera incubation was indistin- 
guishable from background fluorescence observed with sec- 
ondary antibody incubation alone. Background fluorescence 
is seen as a dull haze around the central cluster of nuclei in 
Fig.  7, A  and B. 
Optical sectioning by laser scanning confocal microscopy 
confirmed  that  echistatin  preferentially  localized  to  the 
Figure 6.  Echistatin binding to osteoclasts,  s-echistatin binding to rat and chicken osteoclasts  was shown by labeling  pretreated  cells with 
rabbit polyclonal antisera to echistatin.  After pretreatment with  7 nM s-echistatin  for 10 min at 37°C,  extensive  labeling  of rat (A, C, 
E) but not chicken osteoclasts (B, D, F) occurred. All of these osteoclasts  were labeled  1 d after isolation;  however, similar images were 
obtained for chicken osteoclasts  after 6 d of culture.  Bars,  10 #m. 
Sato et al. Echistatin Inhibits Bone Resorption in Culture  1719 Figure 8.  Laser scanning  confocal microscopy and confocal interference  reflection  microscopy of osteoclasts.  Chicken osteoclasts  were 
incubated  with 7 nM echistatin,  stained  with antisera  (A), and examined (0.5 #m optical section)  at the substrate.  Optical  sectioning  of 
the entire  cell confirmed that echistatin  receptors were preferentially  localized  to the substrate  as no fluorescence  was detected  2.5 ttm 
into the cell. Comparison with mononuclear cells (B-D) near the osteoclast showed that chicken osteoclasts stain more intensely for echista- 
tin,  even when corrected for path length.  Interference patterns  for the same cell  are shown at 458 nm (B) and  514 nm (C).  Numerous 
grey contact regions (spots  and some circles)  are seen  throughout the optical section.  Clusters  of these grey contacts were seen  at the 
periphery of some lamellipodia.  The complex interference  pattern  suggests an undulating  membrane surface  beneath  the osteoclast  with 
much of the cell lifted off the substrate.  The pattern  of grey contacts was similar  for the two wavelengths as seen by combining the 458- 
and 514-nm images (D) (see Bereiter-Hahn et al.,  1979). This shows that reflection off of additional  structures from within the osteoclast 
contributed  little  to this  interference  pattern.  Bar,  10/zm. 
chicken osteoclast/glass  interface  (Fig.  8 A).  The confocal 
microscope focused at this interface showed echistatin stain- 
ing  as  spots  scattered  across  the  optical  section  and  in 
clustered  regions of the periphery  of the lamellipodia. 
The measured intensity for a fluorescent point object un- 
der the confocal imaging conditions for epifluorescence fell 
to half of its maximum value within 0.4 #m on either side 
of focus (Wilson,  1989).  Thus,  Fig.  8 A includes predomi- 
nantly the regions of the cell within •0.5  #m of the glass in- 
terface, with very weak contributions from material outside 
this region. When the focus was set to a depth of 2.5/~m away 
from the glass interface, very little echistatin staining is ob- 
served. Mononuclear cells in rat (Fig. 7 A) and chicken cul- 
tures (Fig.  8 A) showed comparatively little  staining at any 
depth in the cell. 
Confocal interference  reflection microscopy showed that 
osteoclasts attach to glass via small regions scattered across 
the cell surface while most of the cell is lifted off the sub- 
strate (Fig. 8, B-D). Spots and circles of grey contacts were 
observed  across  the  cell/glass  interface,  with  clusters  of 
close contacts at the tips of some lamellipodia. 
For  interference  reflectance  confocal  images,  the  mea- 
sured intensity declined to half maximum within 0.25 #m of 
focus. Thus, the dark interference bands recorded in our in- 
terference  contrast images would be expected to be exclu- 
sively  from zero  order  cancellations.  To  confirm this,  we 
compared the interference reflectance image recorded using 
the wavelengths 458 nm (Fig.  8 B) and 514 nm (Fig.  8  C) 
as described by Bereiter-Hahn et al. (1979). As seen by com- 
bining the two images (Fig. 8 D), the differences between the 
two distributions of grey contacts were minor, which shows 
that reflections off of deeper structures  from within the os- 
teoclast contributed little  to this  image. 
The complex interference pattern suggested a convoluted 
membrane  border  beneath  the  osteoclasts.  Both  of these 
characteristics  were previously described for highly motile 
cells (Bailey and Gingell,  1988; Turksen et al.,  1988).  Fig. 
8,  A  and  D  were  superpositioned  to  show  that  echistatin 
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to  attachment  complexes  at  the  sub- 
strate.  Superpositioning  of  Fig.  8  A 
(yellow) onto 8 D (purple) shows that 
echistatin  receptors  colocalize  to  the 
outer edges of clusters of grey contacts 
found toward the tips of some lamellipo- 
dia. Fainter additional spots of fluores- 
cence (yellow) are seen underneath the 
cell, some but not all of which colocal- 
ize with grey contacts. Bar, 10 t~m. 
localized to the outer areas of clusters of grey contacts ob- 
served in the peripheral lamellipodia (Fig.  9).  s-echistatin 
receptors, therefore, are concentrated in contacts formed by 
osteoclasts with the substrate. 
Receptors for s-echistatin were identified as an integrin by 
double labeling chicken osteoclasts (Fig.  10).  Chicken os- 
teoclasts showed abundant staining for 23C6 (Fig.  10 A), an 
mAb to the cry subunit, and lesser staining for echistatin (7 
nM,  Fig.  10  B).  Superpositioning  of these  micrographs 
showed that 92.8 % of the s-echistatin fluorescence colocal- 
ized  with  23C6  staining,  suggesting  that  the  s-echistatin 
receptor is an integrin with an otv-like subunit. 
Discussion 
Existing theories of how osteoclasts attach  to bone range 
from integrin binding to matrix proteins in bone to the use 
of receptors for proteins with affinity for hydroxyapatite such 
as IgG (Pierce and Lindskog,  1986).  Immunofluorescence 
and  interference  reflection  microscopy  showed  that  os- 
teoclasts organize podosome attachment complexes into a 
circular band on glass  substrates  (Marchisio et al.,  1984; 
Turksen et al., 1988; Zambonin-Zallone et al., 1989). These 
are  highly dynamic attachment complexes previously de- 
scribed for transformed cells (Burridge, 1987; Kanehisa and 
Heersche,  1988;  Turksen et al.,  1988).  However, because 
osteoclasts do not appear to form ruffled borders on glass or 
plastic, the complexes that form on artificial substrates may 
not correlate with the attachment complexes formed at the 
clear zone during bone resorption. 
Recently, a protein named echistatin was purified from the 
venom of the viper Echis carinatus and shown to inhibit the 
ADP-induced aggregation  of platelets  with  an  IC50 of 30 
nM. This peptide contains the Arg-Gly-Asp (RGD) sequence 
but is 100 ×  more potent than the tetrapeptide Arg-Gly-Asp- 
Phe (IC50 =  4-10/~M; Gan et al.,  1988). We therefore used 
s-echistatin to investigate whether the RGD sequence was 
critical to osteoclast function, and thereby implicate a role 
for an RGD-binding protein in bone resorption. 
Integrins  that  recognize the  RGD  sequence  function in 
bone resorption based  on the  following evidence,  s-echi- 
statin at 14 nM completely blocked the association of bone 
with chicken osteoclasts for 150 min and induced the detach- 
ment of rat osteoclasts from glass at 4 nM. Bone resorption 
was inhibited by s-echistatin at 0.1  nM  for rat osteoclast- 
mediated resorption and 0.1/~M for chicken osteoclasts. The 
participation of the RGD sequence and especially Arg  24 in 
this effect was shown by noting that Ala  24 echistatin had no 
significant effect on resorption, osteoclast morphology, at- 
tachment to glass,  or the binding of bone particles to os- 
teoclasts. However, since reduced echistatin had little effect 
on resorption, the tertiary structure contributes to the effects 
of echistatin perhaps by holding the RGD in a preferred con- 
formation. 
The identification of the echistatin receptor as an integrin 
was achieved by observing the colocalization of s-echistatin 
fluorescence with staining for an otv-like subunit. The above 
data plus the colocalization of echistatin with vinculin and 
grey contacts shows that this integrin is associated with func- 
tional attachment complexes formed by osteoclasts to the 
substrate. The functional significance of this "echistatin inte- 
grin" is further supported by noting that 23C6 itself partially 
inhibited the resorption activity of human tumors of giant 
cells (osteoclastomas; Chambers et al.,  1986). 
The identity of the/3 subunit of the echistatin integrin is 
unknown, but previous data with osteoclastomas suggest a 
/33-like subunit  (Horton,  1988;  Zambonin-Zallone  et  al., 
1989; Davies et al., 1989). Our data agrees with the hypoth- 
esis that a vitronectin-like receptor functions in bone resorp- 
tion; however, it remains to be shown if additional integrins 
participate in this process. 
The lack of effect of Ala  24 echistatin on bone resorption 
as  compared to  inhibition of platelet aggregation (IC50 = 
0.5/~M, Garsky et al.,  1989) suggests that platelets and os- 
Sato et al.  Echistatin lnhibits Bone Resorption  in Culture  1721 Figure  10.  The  echistatin  receptor  is  an  integrin.  Chicken  os- 
teoclasts were extracted with 0.1% Triton x-100 (5 min, room tem- 
perature),  fixed, and then incubated with antibodies to s-echistatin, 
followed by 23C6 mAb. This antibody was shown previously to be 
specific for the c~v integrin subunit (Horton,  1988; Davies et al., 
1989). Osteoclasts showed an abundance of staining for 23C6 and 
lesser  fluorescence for s-echistatin.  When micrographs  were su- 
perimposed,  92.8 % of the echistatin  fluorescence  colocalized to 
23C6 staining, suggesting that the echistatin receptor is an integrin 
with an av-like subunit.  Bar, 10/zm. 
teoclasts have pharmacologically distinct integrins to which 
s-echistatin  binds,  s-echistatin  appears  to  compete  with 
fibrinogen for the GP IIb/IIIa complex on human platelets 
(Garsky et al.,  1989).  Biochemical characterization of the 
putative osteoclast integrin(s) to which s-echistatin binds is 
currently under investigation. 
Two differences between the chicken and rat models may 
explain why rat osteoclasts are more sensitive to s-echistatin 
as compared to chickens. First, there are more multinucleate 
cells in the chicken than the rat system. That is, there were 
1,000-5,000  multinucleate  cells/cm  2 for chickens  but  40- 
200/cm  2 for rat.  Because osteoclasts actively release pro- 
teases, the s-echistatin may have been degraded faster in the 
chicken assay. We have found in two of three experiments 
(not shown) that  1 /~M s-echistatin incubated with chicken 
osteoclasts for 3  d  had  insignificant effects on  resorption, 
suggesting that biological activity is lost with time in culture. 
These data plus the abrupt increase in bone binding to os- 
teoclasts at 180 min (Fig. 4) both support the degradation hy- 
pothesis.  Second,  immunofluorescence  intensity  demon- 
strates a greater binding of s-echistatin to rat over chicken 
osteoclasts and mononuclear cells and suggests this is due to 
an  increased  affinity  (Fig.  6).  Additional  experiments are 
in progress to define whether this enhanced binding  is,  in 
fact, a  result of increased affinity or increased numbers of 
receptors. 
The correlation between the microscopic observations of 
lamellipodia retraction and inhibition of bone resorption by 
s-echistatin demonstrate the importance of the integrity of 
osteoclast lamellipodia in bone resorption. The data reported 
here and previous data with cytochalasins (Chambers et al., 
1984)  show that at least two ways exist to induce retraction 
of lamellipodia. That is, cell attachment complexes may be 
destabilized by RGD-containing molecules as shown here or 
actin filament organization may be disrupted.  Since similar 
concentrations of s-echistatin disrupt osteoclast attachment 
to glass and bone resorption, similar structures may be used 
by osteoclasts to adhere to synthetic substrates and bone, as 
implied previously (Turksen et al.,  1988). 
In conclusion,  we have pharmacologically demonstrated 
the  importance  of  the  arginine-glycine-aspartic  acid  se- 
quence in osteoclast-mediated bone resorption and identify 
an integrin with an ~v-like subunit as critical to this process. 
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